versión ISSN 1027-2852
GIL, Miriela R et al. Experiences in the nationwide program for the integral care of the patient with diabetic foot ulcer using Heberprot-P. Biotecnol Apl [online]. 2010, vol.27, n.2, pp. 147-150. ISSN 1027-2852.
Experiences in the nationwide program for the integral care of the patient with diabetic foot ulcer using Heberprot-P. The Cuban product Heberprot-P is indicated for the treatment of complex diabetic foot ulcers (DFU). After its registration in 2006, the product was included into the Cuban List of Medicines and a nationwide program for the integral care of the DFU patient began. To date Heberprot-P is available in more than 85 Cuban health institutions and more than 3 800 diabetic patients with ulcers in their feet have received the benefits of this unique product. An integral program has been established for the attention of the patient with DFU, including the advanced technology of Heberprot-P. This program relies on the closely linked and coordinated interaction between the primary and secondary levels of health, in which prevention and therapy merge each other. The Ministry of Public Health of Cuba has established impact indicators in order to control and assess the performance of the program.
Palabras llave : Heberprot-P; Diabetic foot ulcer; Primary Health Care.